Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
Oscotec Inc.
Oscotec Inc.
AbbVie
AstraZeneca
National Cancer Institute (NCI)
Memgen, Inc.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
M.D. Anderson Cancer Center
Eli Lilly and Company
Spectrum Pharmaceuticals, Inc
Jiangsu HengRui Medicine Co., Ltd.
Canadian Cancer Trials Group
Spanish Breast Cancer Research Group
Novartis
Aileron Therapeutics, Inc.
Pfizer
Calithera Biosciences, Inc
Zhejiang Provincial People's Hospital
Canadian Cancer Trials Group
Hoffmann-La Roche
Pfizer
University of Iowa
Dana-Farber Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
GlaxoSmithKline
Genentech, Inc.
Wake Forest University Health Sciences
SWOG Cancer Research Network
University of Arizona
AmpliMed Corporation
Mirati Therapeutics Inc.
Eli Lilly and Company
Case Comprehensive Cancer Center
Dartmouth-Hitchcock Medical Center
Amgen
Pfizer
Emory University
Azaya Therapeutics, Inc.
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Pfizer